VMP 39696511000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Indoramin 20mg tablets
BNF code 0704010M0AAAAAA
Virtual Therapeutic Moiety Indoramin
Date identifier became valid 26 May 2021
Previous product identifier 318739007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Indoramin hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 395748009
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Doralese Tiltab 20mg tablets (Chemidex Pharma Ltd)
Indoramin 20mg tablets (A A H Pharmaceuticals Ltd)
Indoramin 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Indoramin 20mg tablets (Brown & Burk UK Ltd)
Indoramin 20mg tablets (Essential Generics Ltd)
Indoramin 20mg tablets (Medihealth (Northern) Ltd)
Indoramin 20mg tablets (Phoenix Healthcare Distribution Ltd)
Indoramin 20mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Indoramin 20mg tablets 56 tablet
Indoramin 20mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.